Breezy Med, established in 2019, is transforming hospital infection prevention through innovative automation solutions. The company is headquartered in the United States and operates at the intersection of AI, Automation, Industrial, and Robotics industries.
Their flagship product, Breezy Blue, uses EPA-registered aerosolized hydrogen peroxide (aHP) to deliver whole-room disinfection, effectively surpassing traditional UV systems in both performance and cost-efficiency. The push-button simplicity of Breezy Blue eliminates manual labor and overlooked cleaning spots, presenting a substantial upgrade for terminal cleaning and high-risk areas in hospitals.
Through the Breezy Cloud platform, hospitals gain real-time data access for compliance monitoring and process optimization, significantly reducing healthcare-associated infections (HAIs). After securing a Series A investment on 01 July 2022 from GOS Capital, Breezy Med is well-positioned to further its leadership in modern disinfection technologies.